When we analyzed the two studies in which the percentage of positive TIMP-2 expression was <50% separately, we found that TIMP-2 still had positive prognostic value in NSCLC; the HR was 0.50 (95% CI: 0.28–0.88). This evidence concerns the gene TIMP2 and non-small cell lung carcinoma.